5 months top fin/min.. finally some slight progress? 8/20/2026
The user has been using Hims spray with Minoxidil and Finasteride for 5 months, along with derma rolling and ketoconazole shampoo, and is seeing slight hair regrowth. They are advised to continue the treatment and consider a hair transplant in the future.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity (22M) 4 Months on Topical minoxidil + Topical finasteride + Dermarolling
A 22-year-old male shared his 4-month progress using topical minoxidil, topical finasteride, dermarolling, ketoconazole shampoo, and supplements for hair loss, showing significant improvement. Users discussed his potential for further recovery, shared purchasing tips for finasteride, and mentioned possible side effects like reduced libido.
community Fin/Min/Ketoconazole/Biotin Spray, 9 months results
The user shared 9-month results using a 4-in-1 spray containing finasteride, minoxidil, ketoconazole, and biotin, along with lifestyle changes like jogging, quitting smoking, and using collagen supplements. They also incorporated dermastamping, dermarolling, and various oils into their routine, reporting positive hair regrowth.
community This shedding fase is absolutely brutal
The user is experiencing severe hair shedding despite using minoxidil, finasteride, ketoconazole shampoo, and dermarolling. They are considering changing treatments after stopping dermarolling and switching finasteride brands worsened the shedding.
community Finasteride 0.25mg daily results update - 7months in
Using 0.25mg of finasteride daily for 7 months resulted in thicker hair and slowed hair recession without side effects. The user plans to continue this dosage and may add dermarolling or ketoconazole shampoo for maintenance.
community 9 months oral min, 2 months topical min. Late 30s.
The user used oral finasteride, topical minoxidil foam, a derma roller, keto shampoo, Hims thick fix shampoo, hair dye, and rosemary oil for hair restoration. They reported no side effects and noted significant improvement, especially in the hairline.
Related Research
6 / 6 resultsresearch Comparison of Microneedling with Platelet Rich Plasma vs Minoxidil (5%)+Finasteride (0.1%) Topical Therapy in Androgenetic Alopecia: A Randomised Clinical Study
This study compared the effectiveness and safety of microneedling with PRP versus minoxidil and finasteride topical therapy in adult males with androgenetic alopecia, finding similar hair density improvements in both groups, though microneedling with PRP had a quicker onset of action.
research Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
This review of real-world treatment options for AA indicates that current therapies are insufficient, with high dissatisfaction rates, highlighting a need for improved solutions.
research Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint)
This study observed that patients using a novel topical combination of finasteride and minoxidil for male androgenetic alopecia reported high satisfaction and good tolerance, with few side effects and no need for higher-level care, despite limitations such as retrospective data and no control group.
research Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint)
In this large retrospective study, patients using compounded topical finasteride and minoxidil through a telehealth platform for male androgenetic alopecia reported high satisfaction and low incidence of side effects, with no need for higher care or treatment discontinuation due to adverse reactions.
research Response to Ranpariya et al.’s “Direct-to-consumer teledermatology platforms may have inherent conflicts of interest.”
This article discusses various limitations of direct-to-consumer teledermatology platforms, highlighting concerns regarding ethical issues, financial conflicts of interest, and challenges in providing comprehensive patient care compared to traditional in-person consultations.
research Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
This study found that users of a German direct-to-consumer teledermatology platform for finasteride reported improvements in hair appearance and self-esteem, though 12% experienced treatment-related adverse events.